THERAVANCE BIOPHARMA INC shareholders Q3 2023

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

THERAVANCE BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
BANK OF AMERICA CORP /DE/ 575,558$4,967,0660.00%
Aquatic Capital Management LLC 1,600$140.00%
RHUMBLINE ADVISERS 103,166$890,3080.00%
Tower Research Capital LLC (TRC) 4,727$40,7940.00%
Ensign Peak Advisors, Inc 63,980$552,1470.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 56,016$483,4180.00%
Russell Investments Group, Ltd. 46,503$401,3200.00%
TEACHER RETIREMENT SYSTEM OF TEXAS 14,069$1210.00%
JANE STREET GROUP, LLC 459,511$3,965,5800.00%
MILLENNIUM MANAGEMENT LLC 227,663$1,964,7320.00%
NORTHERN TRUST CORP 556,395$4,801,6880.00%
STATE STREET CORP 1,471,187$12,696,3440.00%
GEODE CAPITAL MANAGEMENT, LLC 1,061,177$9,158,7820.00%
Mirae Asset Global Investments Co., Ltd. 44,532$384,3110.00%
Swiss National Bank 109,042$941,0320.00%
Nuveen Asset Management, LLC 164,588$1,420,3940.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 328,177$2,832,1680.00%
STATE OF WISCONSIN INVESTMENT BOARD 46,965$405,3080.00%
BlackRock Inc. 4,566,930$39,412,6060.00%
Arizona State Retirement System 13,989$120,7250.00%
External links

This page lists THERAVANCE BIOPHARMA INC's shareholders in Q3 2023. To view THERAVANCE BIOPHARMA INC's shareholder history, click here.